GlassScriptPhysician profile
Jamie Heimroth
NPI 1598299406
$16,675.75
in general payments reported to CMS, 2019-2025
7 companies · $9,001 in 2025
The $9,001 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $7,675 · 2025: $9,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $2,010 · Travel and Lodging: $1,956 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $2,009.74 |
| Travel and Lodging | $1,956.02 |
| Education | $209.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,604.42 | 2024-2025 | Pico 7 |
| Stryker Corporation | $2,936.30 | 2024-2025 | Mako, Insignia, Triathlon |
| Medical Device Business Services, INC. | $526.01 | 2024-2025 | Velys |
| Depuy Synthes Sales INC. | $272.52 | 2024-2025 | Attune, Actis |
| Medacta USA, INC. | $150.00 | 2025 | Gmk Sphere |
| Globus Medical, INC. | $148.50 | 2024 | Excelsius3d Imaging System |
| Vertex Pharmaceuticals Incorporated | $38.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Heimroth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.